A clinical trial to measure the cytotoxic activity of lymphocytes increased by dasatinib treatment.
Phase of Trial: Phase II
Latest Information Update: 07 Oct 2012
At a glance
- Drugs Dasatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Pharmacodynamics
- 04 Feb 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 10 Oct 2011 New trial record